Expert Pitch

Cancellation of non-conference college football games may lead to a new battle in the courtroom

Indiana University
10-Jul-2020 1:55 PM EDT, by Indiana University

The Big Ten Conference's decision to cancel all non-conference football games for the upcoming season -- and the possibility that schools in other major conferences may soon follow -- raises a number of potential legal issues, says Nathaniel Grow, associate professor of business law and ethics at the Indiana University Kelley School of Business.  

“Depending on the terms of the schools' college football scheduling agreement, the university cancelling the game may still owe the other school some level of compensation for breaking the agreement,” Grow said. “If the cancelling university refuses to pay, then it would not be surprising if the other school would elect to file a lawsuit.”

A nationally recognized expert in the field of sports law, Grow studied has studied this issue, the subject of a 2010 article in the Journal of College and University Law.

"The ultimate outcome of such a lawsuit would hinge largely on the specific terms of two affected schools' contract. In general, though, two provisions of the contract would likely prove to be the most important. First, most scheduling agreements will include some sort of liquidated damages provision, a clause that specifies that one side of the agreement must pay the other party a certain amount of money should the contract be broken. Often times, these contracts will provide that the breaching party must only pay the other school in the event that the opponent is unable to replace the cancelled game on its schedule with one against a sufficiently suitable alternative opponent. 

"The other relevant clause in these scheduling agreements is likely to be the force majeure provision, sometimes referred to as an ‘Act of God’ clause. Under these provisions, schools may be excused from cancelling a game without penalty if circumstances arise that make playing the game unduly difficult or impossible (for instance, a hurricane or other major weather event). The applicability of such a provision will also vary depending on the specific wording employed in the contract, and whether the clause permits a team to cancel a game on the basis of either a pandemic or a change in conference policy regarding the playing of non-conference games."

Grow can be reached at 812-855-8191 or His mobile number is available on request.

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573